About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 5 record(s)
Req # A-2020-00004
List of mandatory or voluntary training, info sessions, awareness sessions, and sensitivity training from January 1, 2020 to September 2020.Organization: Patented Medicine Prices Review Board Canada
September 2020
Req # A-2020-04135
Copies of the Human Drug Advisory (HDAP) report for erenumab (Aimovig) from January 2018 to February 2020.Organization: Patented Medicine Prices Review Board Canada
September 2020
Req # A-2020-09098
Copies of all records discussing the impacts of the regulatory changes to the PMPRB from August 2019 until August 2020. Copies of all correspondence from all pharmaceutical companies expressing their concerns with the changes and any responses back to these companies. Copies of all correspondence from all advocating groups expressing concerns with the changes and any responses back to these groups. Copies of all correspondence between departmental staff discussing the impacts of the regulatory changes to the PMPRB. Copies of all records discussing the impacts of the PMPRB changes on individuals living with rare diseases. Copies of all correspondence from Vertex Pharmaceuticals relating to Kalydeco, Orkambi, Symdeko, and Trikafta. Copies of all correspondence between government officials (Prime Minister, Ministers, all members of parliament, constituency staff, deputies, assistant deputies, directors, managers, supervisors, staff, and any other employee of the Government of Canada relating to the PMPRB regulatory changes. Copies of all presentations relating to the PMPRB regulatory changes.Organization: Patented Medicine Prices Review Board Canada
September 2020
Req # A-2020-00035
Requesting the medical training and background of all those individuals reviewing and adjudicating on treatment benefits at the First Level (N1LA) and National Second Level of Review. Specifically whether these individuals have specific medical training to make determinations on veteran treatment benefits, their frequency and compensation and whether these individuals are contracted to provide this service or are Government of Canada employees. Requesting a copy of the contract between Blue Cross Medivie and Veteran Affairs Canada for any medical review services or determinations, especially those related to treatment benefits decisions and factors for Veterans. Included should be compensation format between Blue Cross and Veteran Affairs if there is a service contract in place. Requesting any documents that provide the policy and procedures for the decision process pertaining to the First and Second National Level Appeals Unit of Veteran Affairs Canada. Requesting the percentage of approved and denied decisions from both the First and Second Level Appeals Unit over the past three years.Organization: Veterans Affairs Canada
September 2020
Req # A-2019-00095
Requesting a copy of any briefing note(s) to the Minister of Veterans Affairs Canada pertaining to the audit or evaluation of the Disability Pension program between January 1, 2010 and December 31, 2019.Organization: Veterans Affairs Canada
September 2020